Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2007
06/28/2007US20070148663 recombinant nucleic acid which when introduced in vivo into a mammalian cell endogenously expressing EB1, inhibits the expression of EB1 therein, thereby reducing the amount of stable microtubules in the cell; antinflammatory agents
06/28/2007US20070148662 Prostate-specific membrane antigen
06/28/2007US20070148655 Leucine rich repeat containing protein
06/28/2007US20070148287 Cgtase variants
06/28/2007US20070148201 Muteins of a bilin-binding protein with affinity for a given target
06/28/2007US20070148184 Survivin-derived peptides and use thereof
06/28/2007US20070148180 Peptide-immunoglobulin-conjugate
06/28/2007US20070148179 Gankyrin
06/28/2007US20070148176 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
06/28/2007US20070148173 Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of Alpha V Beta 6
06/28/2007US20070148166 Scfvs in photosynthetic microbes
06/28/2007US20070148164 Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
06/28/2007US20070148163 Mutants of anti-cd40 antibody
06/28/2007US20070148160 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
06/28/2007US20070148157 Chondroitinase ABC I polynucleotides
06/28/2007US20070148156 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
06/28/2007US20070148143 Human cytokine receptor
06/28/2007US20070148089 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
06/28/2007DE102005060813A1 Selektive Markierung der Glykane von Antikörpern mit modifizierten Nukleotidzuckern als Substrate von rekombinanten Galactosyltransferasen Selective labeling of glycans of antibodies with modified nucleotide sugars as substrates of recombinant galactosyltransferases
06/28/2007CA2634495A1 Process for the production of preformed conjugates of albumin and a therapeutic agent
06/28/2007CA2634116A1 Anti-ilt7 antibody
06/28/2007CA2633138A1 Methods for generating and screening fusion protein libraries and uses thereof
06/28/2007CA2632435A1 Soluble il-17rc variant and uses thereof
06/27/2007EP1801208A1 Anti-a33 antibody
06/27/2007EP1801204A1 Recombinant herpesvirus of turkeys and uses thereof
06/27/2007EP1801118A1 Process for synthesis of mucin-type peptides and muc1-related glycopeptides
06/27/2007EP1799840A2 Ilt3 polypeptides and uses thereof
06/27/2007EP1799839A2 Increasing the stability of recombinant adult human apohemoglobin
06/27/2007EP1799838A2 Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes
06/27/2007EP1799234A2 Enhancing recombinant hemoglobin production by co-expression with alpha hemoglobin stabilizing protein
06/27/2007EP1385943B1 Novel alkaline protease variants and detergents and cleaning agents containing said novel alkaline protease variants
06/27/2007EP1355936B1 Polymer conjugates of neublastin and methods of using same
06/27/2007EP1305419B1 Modulation by il-tif/interleukin-21
06/27/2007EP1220923B1 FACTOR IX/FACTOR IXa ACTIVATING ANTIBODIES
06/27/2007EP1218519B1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca
06/27/2007EP1110086B1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
06/27/2007CN1989250A Tc-83-derived alphavirus vectors, particles and methods
06/27/2007CN1986829A Preparing process for mannose protein
06/27/2007CN1986828A Fish scale collagen and its production process
06/27/2007CN1986814A Fusion expressed product of vascular inhibine and endostatin in colibacillus and its preparing method
06/27/2007CN1985852A Process of extracting sea cucumber polyose and other active components from boiled sea cucumber juice
06/27/2007CN1323164C Protein complex, process for producing the same and use thereof
06/26/2007US7236891 Methods of determining polypeptide structure and function
06/26/2007US7235709 Transgenic animals with increased slow-twitch muscle fibers and methods of using such animals
06/26/2007US7235652 Transcription activation module comprising nucleotide sequence; vectors for genetic engineering in plants
06/26/2007US7235640 Isolated antibodies to a secretory membrane protein
06/26/2007US7235637 IL-1 eta DNA and polypeptides
06/26/2007US7235633 Cytokine receptors and nucleic acids encoding the same
06/26/2007US7235632 for diagnosing malignant and benign hemopathies; isolated human cell surface protein wherein said protein; expressed at the surface of human lymphoid progenitor cells and mature NK cells
06/26/2007US7235531 Tachykinin-like polypeptides and use thereof
06/26/2007US7235529 Brain-associated inhibitor of tissue-type plasminogen activator
06/26/2007US7235401 Expression vector which comprises live reporter molecule sequence unregulatory control of cell cycle phase-specific expression elements for use in continous monitoring of cell cycle progression
06/26/2007US7235394 Relates to determination of functional HCV virus genomic RNA sequences, construction of infectious HCV DNA clones, and to use of the clones or their derivatives in therapeutic, vaccine, and diagnostic applications
06/26/2007US7235386 Method of increasing complementarity in a heteroduplex
06/26/2007US7235385 Methods for enhancing expression of recombinant proteins
06/26/2007US7235383 Drug screening by contacting interacting domain of presenilin protein with presenilin-binding protein in presence of test subject and measuring interaction of proteins
06/26/2007US7235382 Cell extract from the germ of flowering plants for cell-free protein synthesis, wherein a ribosome deadenylation ratio of the cell extract is 1% or lower; means for cell-free protein synthesis improved in productivity, yield, and simplicity
06/26/2007US7235381 Expressed sequence tags and encoded human proteins
06/26/2007US7235380 CDR-grafted anti-tissue factor antibodies and methods of use thereof
06/26/2007US7235374 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation
06/26/2007US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample
06/26/2007US7235371 Human osteoclast derived cathepsin
06/26/2007US7235366 Methods of identifying agonists and antagonists of opioid receptors
06/26/2007US7235362 Compositions and methods for protein isolation
06/26/2007US7235243 Immunological combination compositions and methods
06/26/2007US7235241 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
06/26/2007US7235238 Antibodies that bind receptor protein designated 2F1
06/26/2007US7235232 Interferon alpha hybrids
06/26/2007CA2265464C Therapy for .alpha.-galactosidase a deficiency
06/26/2007CA2216827C Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
06/26/2007CA2186423C Protein which induces interferon-gamma production by immunocompetent cell
06/26/2007CA2176215C Stable cell lines capable of expressing the adeno-associated virus replication gene
06/26/2007CA2157118C Isolation of components of interest from milk
06/26/2007CA2154445C Lysosomal targeting of immunogens
06/26/2007CA2139862C Use of p97 and iron binding proteins as diagnostic and therapeutic agents
06/26/2007CA2065797C Monoclonal antibody, polypeptide and production thereof
06/21/2007WO2007070659A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
06/21/2007WO2007070315A2 Improved production of glycoproteins using manganese
06/21/2007WO2007069604A1 Method for production of modified protein
06/21/2007WO2007068163A1 Hiv fusion inhibitor peptides and use thereof
06/21/2007WO2007068105A1 Method of diagnosing amyotrophic lateral sclerosis
06/21/2007WO2007024877A3 Compositions and methods for analyzing protein interactions
06/21/2007WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins
06/21/2007WO2006063336A3 Thermostable omega-transaminases
06/21/2007WO2006047242A8 Duffy antigen receptor for chemokines and use thereof
06/21/2007US20070143871 Non-human transgenic animal models for hepatocellular carcinoma
06/21/2007US20070142627 Sugar-chain-altered anti-hm1.24 antibody
06/21/2007US20070142624 Purifying lectin Concanavalin A (Con A) using a buffer in which impurities, such as glycogen and other substances are soluble, but in which the protein remains insoluble
06/21/2007US20070142623 Protein expression system
06/21/2007US20070142312 Antigen delivery system
06/21/2007US20070142295 Thrombopoietic compounds
06/21/2007US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade
06/21/2007US20070142292 Stimulates production of macrophage inflammatory protein from hepatocytes; metal chelator; inhibits bacterial growth
06/21/2007US20070142288 Isolated MCPIP and methods of use
06/21/2007US20070142284 Vascular endothelial cell growth factor variants and uses thereof
06/21/2007US20070142282 Modified VEGF-A with improved angiogenic properties
06/21/2007US20070142280 Factor VII or VIIa-like molecules
06/21/2007US20070142277 Bace455, an alternative splice variant of the human beta-secretase
06/21/2007US20070142275 for the treatment of diseases and pathological alterations associated with excessive or deregulated TGF- beta 1 expression
06/21/2007US20070142274 Fish protein hydrolyzate